Literature DB >> 31992886

This scientist hopes to test coronavirus drugs on animals in locked-down Wuhan.

David Cyranoski.   

Abstract

Entities:  

Keywords:  Diseases; Infection; Virology

Mesh:

Substances:

Year:  2020        PMID: 31992886     DOI: 10.1038/d41586-020-00190-6

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  10 in total

Review 1.  Coronavirus Disease 2019-COVID-19.

Authors:  Kuldeep Dhama; Sharun Khan; Ruchi Tiwari; Shubhankar Sircar; Sudipta Bhat; Yashpal Singh Malik; Karam Pal Singh; Wanpen Chaicumpa; D Katterine Bonilla-Aldana; Alfonso J Rodriguez-Morales
Journal:  Clin Microbiol Rev       Date:  2020-06-24       Impact factor: 26.132

Review 2.  Emerging novel coronavirus (2019-nCoV)-current scenario, evolutionary perspective based on genome analysis and recent developments.

Authors:  Yashpal Singh Malik; Shubhankar Sircar; Sudipta Bhat; Khan Sharun; Kuldeep Dhama; Maryam Dadar; Ruchi Tiwari; Wanpen Chaicumpa
Journal:  Vet Q       Date:  2020-12       Impact factor: 3.320

3.  Epigenetic Landscapes of Single-Cell Chromatin Accessibility and Transcriptomic Immune Profiles of T Cells in COVID-19 Patients.

Authors:  Shun Li; Bin Wu; Yun Ling; Mingquan Guo; Boyin Qin; Xiaonan Ren; Chao Wang; Hua Yang; Lixiang Chen; Yixin Liao; Yang Liu; Xiuhua Peng; Chunhua Xu; Zhenyan Wang; Yinzhong Shen; Jun Chen; Li Liu; Bowen Niu; Mengmin Zhu; Lingling Liu; Feng Li; Tongyu Zhu; Zhaoqin Zhu; Xiaohui Zhou; Hongzhou Lu
Journal:  Front Immunol       Date:  2021-02-24       Impact factor: 7.561

Review 4.  Risk management and communication plans from SARS to COVID-19 and beyond.

Authors:  Virginia Recchia; Alessandra Aloisi; Antonella Zizza
Journal:  Int J Health Plann Manage       Date:  2022-08-19

Review 5.  The Global Emergency of Novel Coronavirus (SARS-CoV-2): An Update of the Current Status and Forecasting.

Authors:  Hossein Hozhabri; Francesca Piceci Sparascio; Hamidreza Sohrabi; Leila Mousavifar; René Roy; Daniela Scribano; Alessandro De Luca; Cecilia Ambrosi; Meysam Sarshar
Journal:  Int J Environ Res Public Health       Date:  2020-08-05       Impact factor: 3.390

Review 6.  COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics.

Authors:  Kuldeep Dhama; Khan Sharun; Ruchi Tiwari; Maryam Dadar; Yashpal Singh Malik; Karam Pal Singh; Wanpen Chaicumpa
Journal:  Hum Vaccin Immunother       Date:  2020-03-18       Impact factor: 3.452

7.  Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing.

Authors:  Wen Wen; Wenru Su; Hao Tang; Wenqing Le; Xiaopeng Zhang; Yingfeng Zheng; Xiuxing Liu; Lihui Xie; Jianmin Li; Jinguo Ye; Liwei Dong; Xiuliang Cui; Yushan Miao; Depeng Wang; Jiantao Dong; Chuanle Xiao; Wei Chen; Hongyang Wang
Journal:  Cell Discov       Date:  2020-05-04       Impact factor: 10.849

Review 8.  From SARS to SARS-CoV-2, insights on structure, pathogenicity and immunity aspects of pandemic human coronaviruses.

Authors:  Nikhil Kirtipal; Shiv Bharadwaj; Sang Gu Kang
Journal:  Infect Genet Evol       Date:  2020-08-13       Impact factor: 3.342

Review 9.  Developmental Landscape of Potential Vaccine Candidates Based on Viral Vector for Prophylaxis of COVID-19.

Authors:  Rajashri Bezbaruah; Pobitra Borah; Bibhuti Bhushan Kakoti; Nizar A Al-Shar'I; Balakumar Chandrasekaran; Da'san M M Jaradat; Munir A Al-Zeer; Saeid Abu-Romman
Journal:  Front Mol Biosci       Date:  2021-04-15

Review 10.  Challenges and prospects of COVID-19 vaccine development based on the progress made in SARS and MERS vaccine development.

Authors:  Jubeda Begum; Nasir Akbar Mir; Kapil Dev; Bidyarani Buyamayum; Mohd Yaqoob Wani; Meesam Raza
Journal:  Transbound Emerg Dis       Date:  2020-09-23       Impact factor: 4.521

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.